Form 4: Slide Insurance CRO Executes Stock Option Exercise
Statement of Changes in Beneficial Ownership
Chief Risk Officer Matthew Larson exercised 10,000 stock options and sold the resulting shares under a 10b5-1 plan.
Summary
- Matthew Paul Larson, Chief Risk Officer of Slide Insurance Holdings, Inc., exercised 10,000 stock options at a strike price of $0.79 per share.
- Following the exercise, the reporting person sold all 10,000 shares at a weighted average price of $18.00 per share.
- The transactions were executed pursuant to a Rule 10b5-1 trading plan adopted on December 4, 2025.
- The reporting person retains 21,250 derivative securities (stock options) following these transactions.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine administrative filing related to executive compensation and personal financial planning, carrying no significant signal regarding company performance.
Positives
- The transaction was pre-planned under a 10b5-1 trading plan, indicating the sale was not based on non-public information.
- The exercise price of $0.79 compared to the sale price of $18.00 reflects significant value appreciation for the executive.
Negatives
- The executive liquidated their entire immediate holding of the exercised shares, resulting in zero direct ownership of the common stock post-transaction.
Risks
- Future sales by insiders may occur as the reporting person still holds 21,250 vested stock options.
Future Outlook
No specific forward-looking guidance regarding company operations was provided in this filing.
Industry Context
StockSavvy.ai notes that insider selling via 10b5-1 plans is a standard practice for executives to manage personal liquidity and diversify portfolios, and is generally viewed as neutral by the market when pre-planned.
Comparison to Industry Standards
- The use of 10b5-1 plans is the industry standard for corporate officers to avoid potential conflicts of interest regarding insider trading regulations.
Stakeholder Impact
- Minimal impact on shareholders as the transaction was conducted under a pre-arranged 10b5-1 plan.
Next Steps
- Continued monitoring of future Form 4 filings for further insider activity.
Key Dates
| Date | Description |
|---|---|
| 12/04/2025 | Date the 10b5-1 trading plan was adopted. |
| 04/13/2026 | Date of the option exercise and subsequent share sale. |
| 04/15/2026 | Date the Form 4 was filed with the SEC. |
Keywords
Slide Insurance, SLDE, Insider Trading, Form 4, Stock Options, 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.